D239baac-figure-01 (Gabapentin 300mg 1)
Gabapentin
Product Images NDC 45865-347
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 45865-347). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
D239baac-figure-02 (Gabapentin 300mg 2)
D239baac-figure-03 (Gabapentin 300mg 3)
This is a chart showing the mean pain scores for a study that involved a 3-week dose titration period and a 4-week fixed dose period. The study involved a placebo group and two groups taking different doses of gabapentin (1800 mg/day and 2400 mg/day). The chart shows that both doses of gabapentin resulted in a significant reduction in pain compared to placebo (p<0.001).*
D239baac-figure-04 (Gabapentin 300mg 4)
The provided text shows a chart depicting the percentage of responders at the endpoint for two different studies (Study 1 and Study 2). The chart displays percentages ranging from 2% to 20% with the label "PBEO" placed in the middle. No further information is provided.*
D239baac-figure-05 (Gabapentin 300mg 5)
Bottle Of 30 (Gabapentin 300mg 6)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
